Sodium risedronate tablets 2.5mg “Kemipha” from Nippon Pharmaceutical Industry contains Risedronate sodium hydrate, a bisphosphonate used for the treatment and prevention of osteoporosis and Paget’s disease of bone. This medication is standardized as 2.5mg per tablet, with YJ code 3999019F1158.
Sodium risedronate tablets 2.5mg “Kemipha”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
